ResMed, Inc. Share Price
Stocks
RMD
US7611521078
Advanced Medical Equipment & Technology
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 197.76 USD | -3.00% |
|
-9.55% | -17.98% |
| 03:10pm | Citigroup Downgrades ResMed to Neutral From Buy, Adjusts Price Target to $235 From $270 | MT |
| 12:18pm | Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34 | MT |
| Market Cap | 2.94TCr 2.58TCr 2.39TCr 2.2TCr 4.16TCr 2,81500Cr 4.24TCr 28TCr 11TCr 1,38200Cr 11TCr 11TCr 4,77300Cr | P/E 2026 * |
19.3x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.86TCr 2.5TCr 2.32TCr 2.13TCr 4.04TCr 2,73300Cr 4.12TCr 28TCr 11TCr 1,34200Cr 11TCr 10TCr 4,63500Cr | EV / Sales 2026 * |
5.05x | EV / Sales 2027 * | 4.54x |
| Free-Float |
75.61% | Yield 2026 * |
1.19% | Yield 2027 * | 1.29% |
Last Transcript: ResMed, Inc.
| 1 day | -3.05% | ||
| 1 week | -9.55% | ||
| Current month | +1.37% | ||
| 1 month | +2.50% | ||
| 3 months | -14.21% | ||
| 6 months | -22.43% | ||
| Current year | -17.98% |
| 1 week | 190.25 |  | 219.98 |
| 1 month | 184.65 | | 222.43 |
| Current year | 180.26 | | 277.67 |
| 1 year | 180.26 | | 293.81 |
| 3 years | 132.24 | | 293.81 |
| 5 years | 132.24 | | 301.34 |
| 10 years | 56.59 | | 301.34 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mick Farrell
CEO | Chief Executive Officer | 53 | 01/03/2013 |
Aaron Bloomer
DFI | Director of Finance/CFO | 40 | 04/05/2026 |
Jim Ellis
CMP | Compliance Officer | - | 01/01/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Ron Taylor
BRD | Director/Board Member | 78 | 01/01/2005 |
Mick Farrell
CHM | Chairman | 53 | 25/01/2023 |
Peter Farrell
CHM | Chairman | 83 | 01/06/1989 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/07 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 08/06 | Fiscal year | Chief Executive Officer | 14,973 | 0.0103% | ||
| 01/06 | Tax | General Counsel | -269 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.00% | -9.55% | -22.26% | -9.67% | 2.94TCr | |
| +0.37% | +2.43% | +24.65% | +0.67% | 20TCr | |
| +0.75% | -5.32% | -20.65% | +18.11% | 14TCr | |
| +0.45% | +3.26% | +1.10% | -16.28% | 14TCr | |
| +0.16% | +0.38% | -57.09% | -15.19% | 6.65TCr | |
| -0.43% | -3.46% | +17.38% | -1.29% | 5.31TCr | |
| +2.80% | +1.95% | -22.68% | -30.55% | 4.41TCr | |
| -0.91% | +2.12% | +11.07% | +11.75% | 3.79TCr | |
| -1.11% | -1.41% | +22.81% | +38.73% | 3.7TCr | |
| +1.23% | +1.00% | -12.03% | -19.55% | 2.94TCr | |
| Average | -0.02% | -0.95% | -5.77% | -2.33% | 7.78TCr | |
| Weighted average by Cap. | +0.25% | -0.90% | -2.07% | -1.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 565.01Cr 495.57Cr 458.99Cr 422.33Cr 798.81Cr 54TCr 814.35Cr 5.47TCr 2.15TCr 27TCr 2.12TCr 2.08TCr 92TCr | 610.1Cr 535.12Cr 495.62Cr 456.02Cr 862.55Cr 58TCr 879.34Cr 5.91TCr 2.32TCr 29TCr 2.29TCr 2.24TCr 99TCr |
| Net income | 154.8Cr 135.77Cr 125.75Cr 115.7Cr 218.85Cr 15TCr 223.11Cr 1.5TCr 587.82Cr 7.28TCr 581.27Cr 568.57Cr 25TCr | 170.74Cr 149.76Cr 138.7Cr 127.62Cr 241.39Cr 16TCr 246.09Cr 1.65TCr 648.37Cr 8.03TCr 641.15Cr 627.13Cr 28TCr |
| Net Debt | -85Cr -74Cr -69Cr -63Cr -120.05Cr -8.13TCr -122.38Cr -822.12Cr -322.44Cr -3.99TCr -318.85Cr -311.88Cr -14TCr | -168.53Cr -147.82Cr -136.91Cr -125.97Cr -238.27Cr -16TCr -242.9Cr -1.63TCr -639.98Cr -7.92TCr -632.85Cr -619.01Cr -27TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $197.55 | -3.10% | 10,74,506 |
| 10/26/10 | $203.87 | -2.20% | 13,31,149 |
| 09/26/09 | $208.45 | +1.27% | 14,79,036 |
| 08/26/08 | $205.84 | -6.33% | 17,61,755 |
| 07/26/07 | $219.75 | +0.62% | 17,26,352 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RMD Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
